OrbiMed’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $77.9M | Sell |
|
|||||
|
2024
Q3 | $158M | Sell |
|
|||||
|
2024
Q2 | $209M | Hold |
|
|||||
|
2024
Q1 | $194M | Buy |
|
|||||
|
2023
Q4 | $214M | Buy |
|
|||||
|
2023
Q3 | $143M | Hold |
|
|||||
|
2023
Q2 | $159M | Buy |
|
|||||
|
2023
Q1 | $140M | Buy |
|
|||||
|
2022
Q4 | $71.5M | Buy |
|
|||||
|
2022
Q3 | $60K | Buy |
|
|||||
|
2022
Q2 | $22.8K | Sell |
|
|||||
|
2022
Q1 | $24.8M | Sell |
|
|||||
|
2021
Q4 | $55.2M | Sell |
|
|||||
|
2021
Q3 | $66.3M | Buy |
|
|||||
|
2021
Q2 | $23.3M | Sell |
|
|||||
|
2021
Q1 | $22.9M | Sell |
|
|||||
|
2020
Q4 | $130M | Sell |
|
|||||
|
2020
Q3 | $203M | Hold |
|
|||||
|
2020
Q2 | $192M | Buy |
|
|||||
|
2020
Q1 | $152M | Buy |
|
|||||
|
2019
Q4 | $19.1M | Buy |
|
|||||
|
2019
Q3 | $8.43M | Sell |
|
|||||
|
2019
Q2 | $20.5M | Hold |
|
|||||
|
2019
Q1 | $20.7M | Sell |
|
|||||
|
2018
Q4 | $251M | Sell |
|
|||||
|
2018
Q3 | $322M | Sell |
|
|||||
|
2018
Q2 | $339M | Buy |
|
|||||
|
2018
Q1 | $285M | Sell |
|
|||||
|
2017
Q4 | $392M | Sell |
|
|||||
|
2017
Q3 | $510M | Hold |
|
|||||
|
2017
Q2 | $442M | Buy |
|
|||||
|
2017
Q1 | $393M | Buy |
|
|||||
|
2016
Q4 | $363M | Sell |
|
|||||
|
2016
Q3 | $418M | Sell |
|
|||||
|
2016
Q2 | $363M | Sell |
|
|||||
|
2016
Q1 | $397M | Buy |
|
|||||
|
2015
Q4 | $442M | Buy |
|
|||||
|
2015
Q3 | $382M | Buy |
|
|||||
|
2015
Q2 | $517M | Buy |
|
|||||
|
2015
Q1 | $510M | Sell |
|
|||||
|
2014
Q4 | $507M | Buy |
|
|||||
|
2014
Q3 | $394M | Buy |
|
|||||
|
2014
Q2 | $342M | Buy |
|
|||||
|
2014
Q1 | $324M | Sell |
|
|||||
|
2013
Q4 | $306M | Buy |
|
|||||
|
2013
Q3 | $247M | Buy |
|
|||||
|
2013
Q2 | $221M | Buy |
|